Rhinocerebral Mucormycosis: Consideration of prognostic factors and treatment modality

Auris Nasus Larynx

Volumn 36, Issue 3, 2009, Pages 274-279

  Jung, Sang Hee ^a   Kim, Sung Won ^a   Park, Chan Soon ^a   Song, Chang Eun ^a   Cho, Jin Hee ^a   Lee, Joo Hyung ^a   Kim, Nam Sik ^a   Kang, Jun Myung ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Prognosis; Rhinocerebral mucormycosis; Treatment

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEBRIDEMENT; DIABETES MELLITUS; DISEASE COURSE; DISEASE PREDISPOSITION; DRUG DOSE INCREASE; EAR SURGERY; EVISCERATION; FEMALE; HEMATOLOGIC DISEASE; HISTOPATHOLOGY; HUMAN; MALE; MAXILLA RESECTION; MORTALITY; MUCORMYCOSIS; NEPHROTOXICITY; NOSE IRRITATION; ORBIT DISEASE; PROGNOSIS; RHINOCEREBRAL MUCORMYCOSIS; SIDE EFFECT; SURGICAL TECHNIQUE;

ADULT; AGED; AMPHOTERICIN B; ANTIFUNGAL AGENTS; BRAIN DISEASES; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; MUCORMYCOSIS; ORBITAL DISEASES; PROGNOSIS; RHINITIS; SURVIVAL RATE;

EID: 64749109052     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anl.2008.07.003     Document Type: Article

References (11)

1. Sundaram C., Mahadevan A., Laxmi V., Yasha C., Santosh V., Murthy J.M., et al. Cerebral zygomycosis. Mycoses 48 (2005) 396-407
2. Yeung C.K., Cheng V.C., Lie A.K., and Yuen K.Y. Invasive disease due to mucorales: a case report and review of the literature. Hong Kong Med J 7 (2001) 180-188
3. Munir N., and Jones N.S. Rhinocerebral mucormycosis with orbital and intracranial extension: a case report and review of optimum management. J Laryngol Otol 121 (2007) 192-195
4. Mohindra S., Gupta R., Bakshi J., and Gupta S.K. Rhinocerebral mucormycosis: the disease spectrum in 27 patients. Mycoses 50 (2007) 290-296
5. Handzel O., Landau Z., and Halperin D. Liposomal amphotericin B treatment for rhinocerebral mucormycosis: how much is enough?. Rhinology 41 (2003) 184-186
6. Cagatay A.A., Oncu S.S., Calangu S.S., Yildirmak T.T., Ozsut H.H., and Eraksoy H.H. Rhinocerebral mucormycosis with 32 g liposomal amphotericin B and incomplete surgery: case report. BMC Infect Dis 1 (2001) 22
7. Sims C.R., and Zeichner L.O. Contemporary treatment and outcomes of zygomycosis in a non-oncologic tertiary care center. Arch Med Res 38 (2007) 90-93
8. Dhiwakar M., Thakar A., and Bahadur S. Improving outcomes in rhinocerebral mucormycosis-early diagnostic pointers and prognostic factors. J Laryngol Otol 117 (2003) 861-865
9. Kim J., Fortson J.K., and Cook H.E. A fatal outcome from rhinocerebral mucormycosis after dental extractions: a case report. J Oral Maxillofac Surg 59 (2001) 693-697
10. Linnea P.K., Marilene W., Rinaldo C., and Elliot A. Rhinocerebral mucormycosis: evolution of the disease and treatment options. Laryngoscope 107 (1997) 855-862
11. Fisher E.W., Toma A., Fisher P.H., and Cheesman A.D. Rhinocerebral mucormycosis: use of liposomal amphotericin B. J Laryngol Otol 105 (1991) 575-577